Room for improvement? A survey of the methods used in systematic reviews of adverse effects

Author:

Golder Su,Loke Yoon,McIntosh Heather M

Abstract

Abstract Background Although the methods for conducting systematic reviews of efficacy are well established, there is much less guidance on how systematic reviews of adverse effects should be performed. Methods In order to determine where methodological research is most needed to improve systematic reviews of adverse effects of health care interventions, we conducted a descriptive analysis of systematic reviews published between 1994 and 2005. We searched the Database of Abstracts of Reviews of Effects (DARE) and The Cochrane Database of Systematic Reviews (CDSR) to identify systematic reviews in which the primary outcome was an adverse effect or effects. We then extracted data on many of the elements of the systematic review process including: types of interventions studied, adverse effects of interest, resources searched, search strategies, data sources included in reviews, quality assessment of primary data, nature of the data analysis, and source of funding. Results 256 reviews were included in our analysis, of which the majority evaluated drug interventions and pre-specified the adverse effect or effects of interest. A median of 3 resources were searched for each review and very few reviews (13/256) provided sufficient information to reproduce their search strategies. Although more than three quarters (185/243) of the reviews sought to include data from sources other than randomised controlled trials, fewer than half (106/256) assessed the quality of the studies that were included. Data were pooled quantitatively in most of the reviews (165/256) but heterogeneity was not always considered. Less than half (123/256) of the reviews reported on the source of funding. Conclusion There is an obvious need to improve the methodology and reporting of systematic reviews of adverse effects. The methodology around identification and quality assessment of primary data is the main concern.

Publisher

Springer Science and Business Media LLC

Subject

Health Informatics,Epidemiology

Reference12 articles.

1. Cuervo LG, Clarke M: Balancing benefits and harms in health care. BMJ. 2003, 327: 65-66. 10.1136/bmj.327.7406.65.

2. Chou R, Helfand M: Challenges in systematic reviews that assess treatment harms. Ann Int Med. 2005, 142: 1090-1099.

3. Loke YK, Price D, Herxheimer A, editors: Including adverse effects. Cochrane Handbook for Systematic Reviews of Interventions 4.2.5 [updated. Edited by: Higgins JPT, Green S. 2005, May ]; Appendix 6b

4. Derry S, Loke YK, Aronson JK: Incomplete evidence: the inadequacy of databases in tracing published adverse drug reactions in clinical trials. BMC Med Res Methodol. 2001, 1: 7-10.1186/1471-2288-1-7.

5. Golder S, Duffy S, Glanville J, McIntosh H, Miles J: Developing efficient search strategies to identify papers on adverse events. A: testing precision and sensitivity [abstract]. 12th Cochrane Colloquium. 2004, 75-76. Oct 2–6; Ottawa, Ontario, Canada

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3